Found 18 matching trials
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial PHASE3 This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM PHASE2 The aim of the trial is to optimize response rates and rates of secondary r...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient PHASE2 This is a phase II randomized study of 4-months induction first-line chemot...
Show More Location
A.O.Universitaria Policlinico S.Orsola-Malpighi Di Bologna (Oncologia Medica)
Learn More & Join Trial
Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer PHASE2 This study will evaluate the efficacy of FOLOFOXIRI plus Cetuximab combinat...
Show More Location
University Hospital of Crete
Learn More & Join Trial
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer PHASE2 PURPOSE:
A primary aim of phase II FOCULM study is to explore whether cetu...
Show More Location
Gastrointestinal Hospital, Sun Yat-sen University
Learn More & Join Trial
Ablation With Systemic Therapy vs Liver Resection With Systemic Therapy for Colorectal Liver Metastasis N/A For patients with colorectal liver metastases (CRLM) â€5 cm, Clinical guidel...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases PHASE2 The aim of this study is to investigate the following schedules for efficac...
Show More Location
UniversitÀtsklinikum der RWTH Aachen
Learn More & Join Trial
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study PHASE2 This prospective Phase II study aims to evaluate the efficacy and safety of...
Show More Location
Al Hussien University Hospital
Learn More & Join Trial
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status PHASE4 The aim of this trial is to assess the feasibility of EREG/AREG assessment ...
Show More Location
Multiple Locations
Learn More & Join Trial
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer PHASE2 The purpose of the present study is to investigate the benefit of anti-canc...
Show More Location
Department of Oncology, Aalborg University Hospital
Learn More & Join Trial